Wednesday, February 10, 2010, 8:15am EST - Canadian Markets open in 1 hour and 15 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Antares Pharma Inc. (AIS)

 On Feb 9: 1.12 USD   0.00 (0.00%)  
MORE ON AIS
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ANTARES PHARMA INC (AMEX:AIS) Delayed quote dataEdit
Last Trade: 1.12 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 1.12
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 3.31
Day's Range: N/A - N/A
52wk Range: 0.30 - 1.35
Volume: 0
Avg Vol (3m): 327,119
Market Cap: 91.52M
P/E (ttm): N/A
EPS (ttm): -0.119
Div & Yield: N/A (N/A%)
Antares Pharma Inc. (AIS)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add AIS to Portfolio   Download Data

HEADLINES
• Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.
GlobeNewswire (Wed, Feb 3)
• ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES Patient-Friendly Injector for Growth Hormone Deficiency in Childr
Business Wire (Tue, Feb 2)
• Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Business Wire (Wed, Jan 20)
• Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
Business Wire (Mon, Jan 11)
• Coverage initiated on Antares Pharma by Roth Capital
Briefing.com (Fri, Jan 8)
• Prospecting for Stocks: Antares Pharma
at Motley Fool (Mon, Dec 28)
• ANTARES PHARMA, INC. Financials
EDGAR Online Financials (Tue, Nov 17)
• ANTARES PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 12)
• Antares Pharma, Inc. Earnings Call scheduled for 4:30 pm ET today
CCBN (Mon, Nov 9)
• ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
EDGAR Online (Mon, Nov 9)
More Headlines for AIS...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Antares Pharma, Inc. operates as a specialty drug delivery/pharmaceutical company. It develops, produces, and markets pharmaceutical delivery products based on three drug delivery platforms: transdermal drug delivery platform, fast-melt oral disin...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices